Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Cancer, Papillary × copanlisib × 90 days × Clear all

Sponsor

Conditions

Lymphoma 3 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Endometrial Neoplasms 2 Triple Negative Breast Neoplasms 1 Malignant Solid Neoplasm 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Fallopian Tube Neoplasms 1 Disease Progression 1

Interventions

entrectinib 2 Magnetic Resonance Spectroscopy 2 tremelimumab 1 trametinib 1 selpercatinib 1 gallium Ga 68 dotatate 1 durvalumab 1 dabrafenib 1 cobimetinib 1 X-Rays 1 Vemurafenib 1 Thyrotropin Alfa 1 Surveys and Questionnaires 1 Specimen Handling 1 Mitoxantrone 1 Iodine-131 1 High-Energy Shock Waves 1 Glycoprotein Hormones, alpha Subunit 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡